BOEING CO/THE (BA) Fundamental Analysis & Valuation

NYSE:BA • US0970231058

Current stock price

205.99 USD
-4.83 (-2.29%)
At close:
205.88 USD
-0.11 (-0.05%)
After Hours:

This BA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BA Profitability Analysis

1.1 Basic Checks

  • BA had negative earnings in the past year.
  • In the past year BA had a positive cash flow from operations.
  • In the past 5 years BA reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: BA reported negative operating cash flow in multiple years.
BA Yearly Net Income VS EBIT VS OCF VS FCFBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B

1.2 Ratios

  • BA's Return On Assets of 1.12% is in line compared to the rest of the industry. BA outperforms 47.44% of its industry peers.
  • BA has a Return On Equity of 34.65%. This is amongst the best in the industry. BA outperforms 93.59% of its industry peers.
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROIC N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BA Yearly ROA, ROE, ROICBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • BA's Profit Margin of 2.11% is in line compared to the rest of the industry. BA outperforms 48.72% of its industry peers.
  • BA's Gross Margin of 4.79% is on the low side compared to the rest of the industry. BA is outperformed by 80.77% of its industry peers.
  • In the last couple of years the Gross Margin of BA has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 2.11%
GM 4.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
BA Yearly Profit, Operating, Gross MarginsBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1

2. BA Health Analysis

2.1 Basic Checks

  • BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BA has been increased compared to 5 years ago.
  • BA has a better debt/assets ratio than last year.
BA Yearly Shares OutstandingBA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BA Yearly Total Debt VS Total AssetsBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that BA is in the distress zone and has some risk of bankruptcy.
  • BA's Altman-Z score of 1.32 is on the low side compared to the rest of the industry. BA is outperformed by 79.49% of its industry peers.
  • BA has a Debt/Equity ratio of 8.37. This is a high value indicating a heavy dependency on external financing.
  • BA has a worse Debt to Equity ratio (8.37) than 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC9.51%
BA Yearly LT Debt VS Equity VS FCFBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • BA has a Current Ratio of 1.19. This is a normal value and indicates that BA is financially healthy and should not expect problems in meeting its short term obligations.
  • BA has a Current ratio of 1.19. This is amonst the worse of the industry: BA underperforms 80.77% of its industry peers.
  • A Quick Ratio of 0.40 indicates that BA may have some problems paying its short term obligations.
  • BA has a Quick ratio of 0.40. This is amonst the worse of the industry: BA underperforms 91.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.4
BA Yearly Current Assets VS Current LiabilitesBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

6

3. BA Growth Analysis

3.1 Past

  • BA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.34%, which is quite impressive.
  • Looking at the last year, BA shows a very strong growth in Revenue. The Revenue has grown by 34.50%.
  • The Revenue has been growing by 8.81% on average over the past years. This is quite good.
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%

3.2 Future

  • Based on estimates for the next years, BA will show a very strong growth in Earnings Per Share. The EPS will grow by 26.39% on average per year.
  • The Revenue is expected to grow by 9.67% on average over the next years. This is quite good.
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.39%
Revenue Next Year9.98%
Revenue Next 2Y12.33%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BA Yearly Revenue VS EstimatesBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B
BA Yearly EPS VS EstimatesBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20

1

4. BA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BA. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 1018.95, which means the current valuation is very expensive for BA.
  • BA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BA is more expensive than 61.54% of the companies in the same industry.
  • BA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE N/A
Fwd PE 1018.95
BA Price Earnings VS Forward Price EarningsBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BA Per share dataBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BA does not grow enough to justify the current Price/Earnings ratio.
  • BA's earnings are expected to grow with 42.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.38%
EPS Next 3Y42.54%

0

5. BA Dividend Analysis

5.1 Amount

  • BA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BA Fundamentals: All Metrics, Ratios and Statistics

BOEING CO/THE

NYSE:BA (3/18/2026, 8:04:00 PM)

After market: 205.88 -0.11 (-0.05%)

205.99

-4.83 (-2.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-27
Earnings (Next)04-21
Inst Owners71.79%
Inst Owner Change2.38%
Ins Owners0.03%
Ins Owner Change5.1%
Market Cap161.77B
Revenue(TTM)89.46B
Net Income(TTM)1.89B
Analysts83.78
Price Target277.93 (34.92%)
Short Float %1.48%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.43
Dividend Growth(5Y)-36.84%
DP17.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.5%
Min EPS beat(2)-179.06%
Max EPS beat(2)-57.93%
EPS beat(4)2
Avg EPS beat(4)-38.78%
Min EPS beat(4)-179.06%
Max EPS beat(4)63.2%
EPS beat(8)4
Avg EPS beat(8)-30.95%
EPS beat(12)6
Avg EPS beat(12)-17.74%
EPS beat(16)6
Avg EPS beat(16)-664.18%
Revenue beat(2)2
Avg Revenue beat(2)2.86%
Min Revenue beat(2)2.82%
Max Revenue beat(2)2.89%
Revenue beat(4)3
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.89%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-3.25%
PT rev (1m)0.64%
PT rev (3m)8.31%
EPS NQ rev (1m)2.9%
EPS NQ rev (3m)-1126.68%
EPS NY rev (1m)0%
EPS NY rev (3m)-90.59%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1018.95
P/S 1.81
P/FCF N/A
P/OCF 151.9
P/B 29.66
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.32
EYN/A
EPS(NY)0.2
Fwd EY0.1%
FCF(TTM)-2.4
FCFYN/A
OCF(TTM)1.36
OCFY0.66%
SpS113.91
BVpS6.94
TBVpS-17.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.11%
GM 4.79%
FCFM N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.1%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.4
Altman-Z 1.32
F-Score6
WACC9.51%
ROIC/WACCN/A
Cap/Depr(3y)119.8%
Cap/Depr(5y)93.37%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.39%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%
Revenue Next Year9.98%
Revenue Next 2Y12.33%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year229.27%
EBIT Next 3Y75.68%
EBIT Next 5Y46.89%
FCF growth 1Y86.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.82%
OCF growth 3Y-32.82%
OCF growth 5YN/A

BOEING CO/THE / BA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BOEING CO/THE (BA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BA.


What is the valuation status for BA stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BA). This can be considered as Overvalued.


Can you provide the profitability details for BOEING CO/THE?

BOEING CO/THE (BA) has a profitability rating of 2 / 10.


Is the dividend of BOEING CO/THE sustainable?

The dividend rating of BOEING CO/THE (BA) is 0 / 10 and the dividend payout ratio is 17.51%.